The statistic displays the market size of therapeutic agents for osteoporosis in Japan in 2014 and 2016 with a forecast for 2024. In 2016, the source evaluated the market size to reach approximately 2.6 trillion Japanese yen. This figure was estimated to increase to around 3.8 trillion yen in 2024.
Market size of therapeutic agents for osteoporosis in Japan in 2014 and 2016 with a forecast in 2024 (in trillion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Japan
Overview
4
- Premium Statistic Global pharmaceutical market - revenue distribution 2010-2021, by region
- Premium Statistic Number of medical drug manufacturing plants Japan 2021, by production value
- Premium Statistic Total asset of major companies in pharmaceutical industry Japan 2021
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2021
Production
5
- Premium Statistic Production value of pharmaceutical drugs Japan 2012-2021
- Premium Statistic Share of drug production value Japan 2012-2021, by type
- Premium Statistic Share of drug production value Japan 2021, by category
- Premium Statistic Share of drug production value Japan 2021, by drug form
- Premium Statistic Production value of prescription drugs Japan 2012-2021
International trade
4
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2012-2021
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2012-2021
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2021, by region
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2021, by region
Sales
5
- Premium Statistic Prescription and OTC drug wholesales share in Japan FY 1990-2020
- Premium Statistic Prescription drug market size Japan 2002-2021
- Premium Statistic Share of prescription drug sales Japan FY 2011-2020, by channel
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Premium Statistic Sales value of leading drugs Japan FY 2021
Expenditure
4
- Premium Statistic R&D spending of pharmaceutical companies in relation to sales Japan FY 2015-2021
- Premium Statistic R&D spending of pharmaceutical companies Japan FY 2015-2021
- Premium Statistic R&D expenditure of leading pharmaceutical manufacturers Japan 2020
- Premium Statistic Ad expenses of the pharmaceuticals industry Japan 2012-2021
Approval and patent
5
- Premium Statistic Number of pharmaceutical products approved by PMDA Japan FY 2020, by type
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2020, by type
- Premium Statistic Number of new drugs approved by PMDA Japan FY 2014-2020
- Premium Statistic Number of patents in the pharmaceutical industry Japan 2021, by type
- Premium Statistic Companies with the highest number of pharmaceutical patent applications Japan 2021
Leading companies
6
- Premium Statistic Major pharmaceutical companies in prescription drug sales Japan 2021, by distributor
- Premium Statistic Net sales of leading generics makers Japan 2020
- Basic Statistic Takeda Pharmaceutical's revenue FY 2012-2021
- Basic Statistic Otsuka Holdings' net sales FY 2012-2021
- Basic Statistic Astellas Pharma's revenue FY 2012-2021
- Basic Statistic Daiichi Sankyo's revenue FY 2012-2021
Coronavirus (COVID-19)
3
Further related statistics
11
- Export value medical equipment Indonesia 2019-2022
- Generic drug sales in Mexico as share of total pharmaceutical sales 2015-2025
- Import value of medical equipment Indonesia 2019-2022
- Drug production value share of digestive organ agents Japan 2018, by category
- Distribution of the pharmaceutical market Indonesia 2015 by drug type
- Distribution of Mexican pharmaceutical exports in 2016, by country
- Forecasted generic drug sales in Mexico 2015-2025
- Drug production value of digestive organ agents Japan 2016, by category
- Pharmaceutical market value Indonesia 2011-2016
- Number of pharmaceutical companies Indonesia 2018 by region
- Forecasted Mexican pharmaceutical exports 2016-2020
Further Content: You might find this interesting as well
Statistics
- Export value medical equipment Indonesia 2019-2022
- Generic drug sales in Mexico as share of total pharmaceutical sales 2015-2025
- Import value of medical equipment Indonesia 2019-2022
- Drug production value share of digestive organ agents Japan 2018, by category
- Distribution of the pharmaceutical market Indonesia 2015 by drug type
- Distribution of Mexican pharmaceutical exports in 2016, by country
- Forecasted generic drug sales in Mexico 2015-2025
- Drug production value of digestive organ agents Japan 2016, by category
- Pharmaceutical market value Indonesia 2011-2016
- Number of pharmaceutical companies Indonesia 2018 by region
- Forecasted Mexican pharmaceutical exports 2016-2020
Fuji Keizai Group. (December 13, 2016). Market size of therapeutic agents for osteoporosis in Japan in 2014 and 2016 with a forecast in 2024 (in trillion Japanese yen) [Graph]. In Statista. Retrieved May 29, 2023, from https://www.statista.com/statistics/769981/market-size-therapeutic-osteoporosis-agents/
Fuji Keizai Group. "Market size of therapeutic agents for osteoporosis in Japan in 2014 and 2016 with a forecast in 2024 (in trillion Japanese yen)." Chart. December 13, 2016. Statista. Accessed May 29, 2023. https://www.statista.com/statistics/769981/market-size-therapeutic-osteoporosis-agents/
Fuji Keizai Group. (2016). Market size of therapeutic agents for osteoporosis in Japan in 2014 and 2016 with a forecast in 2024 (in trillion Japanese yen). Statista. Statista Inc.. Accessed: May 29, 2023. https://www.statista.com/statistics/769981/market-size-therapeutic-osteoporosis-agents/
Fuji Keizai Group. "Market Size of Therapeutic Agents for Osteoporosis in Japan in 2014 and 2016 with a Forecast in 2024 (in Trillion Japanese Yen)." Statista, Statista Inc., 13 Dec 2016, https://www.statista.com/statistics/769981/market-size-therapeutic-osteoporosis-agents/
Fuji Keizai Group, Market size of therapeutic agents for osteoporosis in Japan in 2014 and 2016 with a forecast in 2024 (in trillion Japanese yen) Statista, https://www.statista.com/statistics/769981/market-size-therapeutic-osteoporosis-agents/ (last visited May 29, 2023)
Market size of therapeutic agents for osteoporosis in Japan in 2014 and 2016 with a forecast in 2024 (in trillion Japanese yen) [Graph], Fuji Keizai Group, December 13, 2016. [Online]. Available: https://www.statista.com/statistics/769981/market-size-therapeutic-osteoporosis-agents/